How PGT-A Enhances IVF Success Rates and Outcomes?
Embarking on the IVF journey is a path filled with hope, anticipation, and sometimes, anxiety. At Allahbadia IVF, we understand the profound emotional and financial investment in building your family.
That’s why we dedicate ourselves to providing cutting-edge reproductive technologies to boost your chances of a healthy pregnancy and a successful live birth.
Among these innovations, Preimplantation Genetic Testing for Aneuploidy, or PGT-A, stands out as a powerful tool for transforming IVF success rates and outcomes.
For many couples, unexplained recurrent miscarriages or multiple failed IVF cycles can be heartbreaking. Often, these challenges stem from chromosomal abnormalities in the embryo, which are largely invisible without specialized testing.
PGT-A treatment offers a crucial window into an embryo’s genetic health before it is transferred. This enables us to choose the healthiest embryos, greatly increasing the likelihood of pregnancy success and a healthy child.
What is PGT-A? Understanding the science behind better outcomes
Preimplantation Genetic Testing PGT-A is a genetic test performed on embryos created during an IVF cycle. Its primary purpose is to identify chromosomal abnormalities, specifically aneuploidies. Aneuploidy means having an abnormal number of chromosomes in a cell, either extra or missing ones. Normal cells typically have 23 pairs of chromosomes (46 in total) for humans. Here’s how PGT-A works:
IVF cycle: Eggs and sperm are brought together in Allahbadia IVF’s advanced lab for fertilization, resulting in embryo formation.
Embryo biopsy: At the blastocyst stage (day 5 or 6), a small number of cells are carefully biopsied from the trophectoderm, the future placenta. This biopsy does not affect the inner cell mass, which develops into the fetus.
Genetic analysis: These biopsied cells are then sent to a specialized genetic laboratory for analysis. Advanced techniques are used to count the number of chromosomes in each cell and detect any missing or extra chromosomes.
Embryo classification: Based on the results, embryos are categorized as:
- Euploid: Chromosomally normal (46 chromosomes).
- Aneuploid: Chromosomally abnormal (too many or too few chromosomes).
- Mosaic: Containing a mixture of both normal and abnormal cells.
Embryo selection: Only euploid embryos are selected for transfer into the uterus. Aneuploid embryos are typically not transferred as they are doubtful to result in a successful pregnancy or often lead to miscarriage or the birth of a child with a chromosomal disorder (e.g., Down syndrome).
The transformative benefits of PGT-A
The benefits of PGT-A are profound and multifaceted, leading to a more efficient and emotionally less taxing IVF journey:
- Increased pregnancy rates: PGT-A ensures only chromosomally normal embryos are transferred, boosting pregnancy success per transfer and reducing the number of transfers needed.
- Reduced miscarriage rates: By avoiding embryos with chromosomal abnormalities, PGT-A lowers the risk of early miscarriage.
- Higher live birth rates: Selecting healthy embryos increases the chance of a full-term, healthy baby.
- Reduced time to pregnancy: Fewer failed cycles and miscarriages mean faster success and less time in IVF.
- Lower risk of multiple pregnancies: Higher success rates per transfer reduce the need to implant multiple embryos, lowering risk of twins or triplets.
- Prevention of chromosomal disorders: PGT-A helps avoid embryos that could cause genetic conditions.
- Improved IVF efficiency: PGT-A picks the best embryos early on, especially for older women or those with repeated IVF failures.
- Better use of frozen embryos: Only healthy embryos are frozen, improving chances of future transfers.
Who can benefit from PGT-A treatment?
While PGT-A can potentially benefit any couple undergoing IVF, it is particularly recommended for:
- Women of advanced maternal age: A woman’s age significantly increases the risk of embryo chromosomal abnormalities.
- Couples with recurrent miscarriages: A history of multiple miscarriages often indicates underlying chromosomal issues.
- Couples with repeated IVF failures: When previous IVF cycles have not resulted in pregnancy, PGT-A can help pinpoint chromosomal factors.
- Men with severe male factor infertility: Certain sperm abnormalities can be linked to higher rates of aneuploidy.
- Couples with previous pregnancy affected by chromosomal abnormality: To prevent recurrence.
- Couples considering single embryo transfer (SET): PGT-A helps select the most viable embryo for transfer, reducing risks.
At Allahbadia IVF, our experienced team will thoroughly evaluate your situation and discuss whether PGT-A treatment is the right choice, integrating it seamlessly into your personalized IVF plan.
PGT-A treatment at Allahbadia IVF: Your partner in success
At Allahbadia IVF, we are committed to utilizing the latest advancements in reproductive medicine to give you the best chance of building your family.
Our leading genetic laboratory ensures accurate and reliable PGT-A results. We believe in empowering our patients with knowledge and offering tailored solutions.
Including PGT-A in your IVF process helps shorten the time to pregnancy, lessen the emotional toll of failed attempts, and increase your chances of having a healthy baby.
Contact us today to learn more about how PGT-A can enhance your IVF success rates and outcomes and to schedule a consultation with our fertility specialists. Your journey to parenthood begins with informed choices and compassionate care.
